Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 68Active not recruiting 16Terminated 12Unknown 5Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 3Sarcoma 2Genitourinary 1

Conditions

Ovarian Neoplasms 2Sarcoma, Alveolar Soft Part 1Sarcoma 1Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinosarcoma 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Interventional × cediranib × Clear all
NCT03741426 2023-06-07

WIRE

Cambridge University Hospitals NHS Foundation Trust

Phase 2 Unknown
60 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT03278717 2022-09-27

ICON9

University College, London

Phase 3 Unknown
330 enrolled
Gynecologic

Ovarian Neoplasms

NCT03570437 2022-03-02

COPELIA

University of Manchester

Phase 2 Unknown
124 enrolled
GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

NCT01337401 2019-01-24

CASPS

Institute of Cancer Research, United Kingdom

Phase 2 Unknown
36 enrolled
Sarcoma

Sarcoma, Sarcoma, Alveolar Soft Part

NCT00532194 2015-09-23

ICON6

Medical Research Council

Phase 3 Unknown
486 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡